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Figure 1 Alignment of genomic nucleotide sequence in the Bed-
ouin family, FHR1 and HF. The start of the exon is indicated by an
arrow and the termination codons are shaded in gray. All nucleotide
differences are in the unshaded boxes. The primer sequence used by
Ying et al. is shown as a blackened bar under the nucleotide sequence,
and the primer sequence that we used is shown by the gray-shaded
bar. (Abbreviations: bed, Bedouin family; hfr, factor H-related protein
1; HF, Factor H)
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Complement Factor H Gene Mutation Associated
with Autosomal Recessive Atypical Hemolytic Uremic
Syndrome
To the Editor:
We congratulate Ying et al. (1999) on their study dem-
onstrating failure of secretion of factor H in a family
with autosomal recessive hemolytic uremic syndrome
(HUS) (MIM 235400). Their study indicates factor H
(HF) involvement in the recessive form of the disease as
well as the autosomal dominant form (Warwicker et al.
1998). HF is a member of the regulators of complement
activity gene cluster that includes four factor H–related
proteins (FHR1-4) (Zipfel and Skerka 1994). All se-
creted proteins encoded by this gene family are organized
into repetitive elements known as short consensus re-
peats (SCRs) or complement control protein modules,
and, generally, each SCR is encoded by one exon. We
have found it difficult to design HF exon 20 specific
primers because of the sequence similarity between HF
exons 18–20 and FHR1 exons 3–5. We have now de-
signed an intronic forward primer and a reverse primer
in the 3′ untranslated region and have confirmed their
specificity by sequencing PCR products.
Ying et al. state that they have identified a point mu-
tation in HF exon 20, the last coding exon of the gene.
We were also sent DNA samples from two affected in-
dividuals from this Bedouin pedigree and found them to
be homozygous for microsatellites spanning HF. We am-
plified exon 20 by means of the primers shown in figure
1. Electrophoresis of the product through a 2% agarose
gel indicated a single smaller product, and sequencing
revealed a T substitution and a 24-bp deletion. The effect
of this is to replace the last seven amino acids of the
protein with three different amino acids, as shown in
figure 2. Crucially, this deletes the final cysteine residue.
Each SCR has four cysteine residues at conserved po-
sitions that form two disulphide bridges essential for
protein folding (Janatova et al. 1989). Mutations that
disrupted these disulphide bridges led to a profound se-
cretion block in a child with HF deficiency and mem-
branoproliferative glomerulonephritis (Ault et al. 1997;
Schmidt et al. 1999.
The change reported by Ying et al. is present in FHR1
exon 5, although these investigators did not observe the
second nucleotide substitution in FHR1 exon 5. The
forward and reverse primers used by Ying et al. are com-
plementary to both HF and FHR1 (fig. 1). The reverse
primer overlaps the deletion in the Bedouin family (fig.
1) and, hence, these primers will amplify FHR1 exon 5
but not HF exon 20 in the affected individuals.
In the discussion, the authors suggest that the recessive
form of HUS results from HF deficiency and the dom-
inant form results from the presence of abnormal HF
protein in serum. However, in the isolated case that we
reported, with an exon 1 mutation, the HF levels were
half the normal level. Why did our patient develop HUS
whereas the heterozygotes in the Bedouin family did not,
and why did the child with abnormal HF secretion de-
scribed by Ault develop membranoproliferative glomer-
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Figure 2 Alignment of the amino acid sequence of exon 20 in the Bedouin family, FHR1 exon 5 and HF exon 20. The two amino acid
differences between FHR1 exon 5 and HF exon 20 are in the boxes. (Abbreviations: bed, Bedouin family; hfr, factor H-related protein 1; HF,
Factor H)
ulonephritis rather than HUS? These unanswered ques-
tions emphasize the need for further investigation of the
genotype-phenotype correlations in FH abnormalities.
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Reply to Buddles et al.
To the Editor:
We congratulate Buddles et al. on their thorough eval-
uation of the factor H gene and on the identification of
a mutation that we failed to detect in our study. The
primary conclusions of our study were that (1) on the
basis of segregation in a large Bedouin kindred with
flanking microsatellite markers, hemolytic uremic syn-
drome can be inherited as an autosomal recessive disease
tightly linked to the factor H locus, and (2) the affected
Bedouin patients have abnormal cellular transport of
factor H. These conclusions remain unchanged and are,
in fact, strengthened by the excellent work of Buddles
et al. We agree with their conclusion that further inves-
tigation of genotype-phenotype correlations in factor H
abnormalities are needed to answer a number of inter-
esting questions.
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